Pelago

Pelago - The World's First Digital Clinic for Substance Use Management

High-Level Overview

Pelago is a pioneering virtual clinic that provides personalized digital treatment programs for substance use management, addressing tobacco, alcohol, opioid, and cannabis use. It combines cognitive behavioral therapy (CBT) with medication-assisted treatment (MAT) to deliver accessible, scalable, and confidential care primarily to adults through partnerships with employers, health plans, and wellness platforms. Pelago’s mission is to break down barriers to effective substance use care by offering evidence-based, technology-driven solutions that improve health outcomes and reduce healthcare costs. To date, Pelago has supported over 750,000 members, demonstrating significant growth and impact in the digital health and behavioral health startup ecosystem[1][2][3][7].

For an investment firm perspective, Pelago exemplifies a mission-driven investment philosophy focused on digital health innovation, particularly in behavioral and substance use disorder treatment. It operates at the intersection of healthcare, technology, and employee wellness, sectors that are rapidly expanding due to increasing demand for accessible mental health solutions. Pelago’s impact on the startup ecosystem includes advancing virtual care models and integrating clinical rigor with scalable digital platforms, setting a benchmark for future health tech ventures.

For a portfolio company perspective, Pelago builds a comprehensive digital clinic platform that serves individuals struggling with substance use disorders, employers, and health plans. It solves the problem of limited access to effective, stigma-free substance use treatment by providing on-demand, personalized care that integrates therapy, medication, and remote monitoring. Pelago’s growth momentum is strong, supported by recent $58 million Series C funding and partnerships expanding access to millions of users[1][7][8].

---

Origin Story

Pelago was founded in 2015 in New York, originally known as Quit Genius. The company was started by a team with backgrounds in behavioral health, technology, and clinical care, motivated by the need to transform substance use treatment through digital innovation. The idea emerged from recognizing the barriers to traditional in-person treatment—such as stigma, cost, and accessibility—and leveraging digital tools to provide scalable, evidence-based care. Early traction included successful integration with employers and health plans, demonstrating measurable reductions in substance use and improved member outcomes, which validated the model and fueled further growth[1][3][7].

---

Core Differentiators

• Comprehensive Digital Clinic Model: Combines cognitive behavioral therapy (CBT), medication-assisted treatment (MAT), and remote monitoring tools (e.g., breathalyzers, urinary test kits) in one platform.
• Personalized Treatment Plans: Tailored to individual health profiles, habits, genetics, and goals, enabling flexible care pathways (Support, Manage, Treat).
• Physician-Led Care Team: Access to licensed clinicians, counselors, and coaches providing continuous, confidential support.
• Integration with Employers and Health Plans: Seamless embedding into employee benefits and wellness programs, facilitating broad reach and scalability.
• Evidence-Based Outcomes: Demonstrated reductions in substance use (e.g., 62% reduction in alcohol use within 30 days) and validated ROI for employers.
• Accessibility and Cost-Effectiveness: Virtual delivery removes geographic and stigma barriers, offering care at a fraction of traditional treatment costs.
• Community and Ecosystem Partnerships: Collaborations with inpatient treatment centers and specialty care platforms enhance continuity of care[1][2][4][5][7][8].

---

Role in the Broader Tech Landscape

Pelago rides the growing trend of digital health transformation, particularly in behavioral health and substance use disorder treatment. The timing is critical as the demand for accessible mental health services surges, driven by increased awareness, destigmatization, and the COVID-19 pandemic’s acceleration of telehealth adoption. Market forces favor Pelago’s model due to rising employer interest in workforce wellbeing, regulatory support for telemedicine, and advances in digital therapeutics. Pelago influences the broader ecosystem by setting a standard for integrating clinical rigor with digital convenience, encouraging innovation in virtual care delivery and expanding the reach of evidence-based substance use treatment[1][3][7][9].

---

Quick Take & Future Outlook

Pelago is poised for continued expansion, leveraging recent funding to scale its virtual clinic and deepen integrations with health plans and employers. Future trends shaping its journey include increasing adoption of digital therapeutics, growing employer investment in behavioral health benefits, and advances in remote monitoring technologies. Pelago’s influence is likely to evolve as it broadens its service offerings, potentially incorporating AI-driven personalization and expanding into new markets or age groups. Its leadership in digital substance use management positions it to be a key player in the ongoing transformation of behavioral health care, fulfilling its mission to make effective substance use treatment universally accessible and stigma-free[7][8].

This trajectory ties back to Pelago’s foundational vision of breaking down barriers to care through technology, creating a scalable, impactful solution that meets the urgent needs of individuals and organizations alike.